​
​

Mirum Pharmaceuticals (MIRM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Mirum Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$186.37M

Latest Revenue (Q)

$77.88M

Main Segment (Y)

Product

Main Geography (Y)

UNITED STATES

Mirum Pharmaceuticals Revenue by Period

Mirum Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-141.85%
2022-12-31-302.66%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31--

Mirum Pharmaceuticals generated $186.37M in revenue during NA 2023, up 141.85% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Mirum Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30-12.50%
2024-03-31--0.48%
2023-12-31-45.74%
2023-09-30-27.28%
2023-06-30-18.67%
2023-03-31-13.23%
2022-12-31-48.59%
2022-09-30-7.41%
2022-06-30-35.62%
2022-03-31-310.83%
2021-12-31--37.24%
2021-09-30--54.55%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30--

Mirum Pharmaceuticals generated $77.88M in revenue during Q2 2024, up 12.50% compared to the previous quarter, and up 246.46% compared to the same period a year ago.

Mirum Pharmaceuticals Revenue Breakdown

Mirum Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
License Revenue---
Product---
License---

Mirum Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (95.98%), and License Revenue (4.02%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Product----------
License and Other Revenue----------
License Revenue----------
License----------

Mirum Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (99.92%), and License and Other Revenue (0.08%).

Mirum Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23
UNITED STATES-
Rest of World-

Mirum Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (82.01%), and Rest of World (17.99%).

Quarterly Revenue by Country

CountrySep 24Mar 24
Rest Of World--
UNITED STATES--

Mirum Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (81.84%), and Rest Of World (18.16%).

Mirum Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
AMLXAmylyx Pharmaceuticals--
APLSApellis Pharmaceuticals--
IMCRImmunocore--
BPMCBlueprint Medicines--
MIRMMirum Pharmaceuticals--
ARQTArcutis Biotherapeutics--
VECTVectivBio--
LYRALyra Therapeutics--
XFORX4 Pharmaceuticals--
DAWNDay One Biopharmaceuticals--
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
CERECerevel Therapeutics--
TERNTerns Pharmaceuticals--
LRMRLarimar Therapeutics--
KALVKalVista Pharmaceuticals--
MLTXMoonLake Immunotherapeutics--

MIRM Revenue FAQ

What is Mirum Pharmaceuticals’s yearly revenue?

Mirum Pharmaceuticals's yearly revenue for 2023 was $186.37M, representing an increase of 141.85% compared to 2022. The company's yearly revenue for 2022 was $77.06M, representing an increase of 302.66% compared to 2021. MIRM's yearly revenue for 2021 was $19.14M, representing an increase of 100.00% compared to 2020.

What is Mirum Pharmaceuticals’s quarterly revenue?

Mirum Pharmaceuticals's quarterly revenue for Q2 2024 was $77.88M, a 12.50% increase from the previous quarter (Q1 2024), and a 107.68% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $69.22M, a -0.48% decrease from the previous quarter (Q4 2023), and a 119.07% increase year-over-year (Q1 2023). MIRM's quarterly revenue for Q4 2023 was $69.55M, a 45.74% increase from the previous quarter (Q3 2023), and a 149.24% increase year-over-year (Q4 2022).

What is Mirum Pharmaceuticals’s revenue growth rate?

Mirum Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 873.84%, and for the last 5 years (2019-2023) was 0%.

What are Mirum Pharmaceuticals’s revenue streams?

Mirum Pharmaceuticals's revenue streams in c 23 are License Revenue, and Product. License Revenue generated $7.5M in revenue, accounting 4.02% of the company's total revenue Product generated $178.87M in revenue, accounting 95.98% of the company's total revenue, up 138.30% year-over-year.

What is Mirum Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Mirum Pharmaceuticals was Product. This segment made a revenue of $178.87M, representing 95.98% of the company's total revenue.